ENT Partners accelerates patient outcomes, reduces overhead with EnsoSleep PPG
To streamline the home testing process, reduce device costs, and expedite patient outcomes, ENT Partners adopted EnsoSleep PPG, an FDA-Cleared, AI-Powered Sleep Diagnostic SaMD that leverages data from pulse oximeters.